The homeobox gene Cdx1 is involved in anteroposterior patterning in embryos and its expression selectively persists in the intestinal epithelium throughout life. In human colon cancers, Cdx1 is overexpressed in few cases and lost in the majority of adenocarcinomas. We used mouse models of gain and loss-of-function to investigate the role of Cdx1 in intestinal development and cancers. Transgenic mice overexpressing Cdx1 and knockout mice exhibited a morphologically normal intestine. Cell proliferation, specification into the four differentiated lineages and migration along the crypt-villus axis were unchanged compared to wild-type mice. Changing Cdx1 caused an inverse and dose-dependent modification of the expression of the paralogous gene Cdx2, indicating that Cdx1 fine-tunes Cdx2 activity. Transgenenic and knockout mice failed to spontaneously develop tumours. Overexpressing Cdx1 was without incidence on the frequency of intestinal tumours induced chemically by azoxymethane treatment or genetically in Apc D14/ þ mice. However, it augmented the severity of the tumours in Apc D14/ þ mice. Inversely, the loss-of-function of Cdx1 in knockout mice was without incidence on the growth of tumours induced by azoxymethane. We conclude that Cdx1 is dispensable for intestinal development and that its overexpression could increase malignancy in early stages of tumourigenesis.
The transcription factors encoded by the three homeobox genes of the Cdx family play multiple functions during early development, both extraembryonically and embryonically. By mid-gestation onward, they are turned off except for Cdx1 and Cdx2 in the gut epithelium and Cdx4 in haematopoietic stem cells (Bansal et al., 2006) . In the gut, Cdx2 is crucial for intestinal fate specification and differentiation (Beck et al., 1999) , and it also has a tumour suppressor function in the adult colon (Bonhomme et al., 2003; Gross et al., 2008) . Cdx1 is the second gutspecific Cdx-type gene. The protein increases along the gut length, being restricted to the crypts in the small intestine and expressed in the bottom four-fifths of the colonic glands . Although the role of Cdx1 has been unveiled in body axis patterning (Subramanian et al., 1995) , its relevance remains elusive in the gut. In intestinal cells cultured in vitro, Cdx1 stimulates differentiation (Soubeyran et al., 1999) and either stimulates (Lorentz et al., 1997; Soubeyran et al., 1999) or inhibits proliferation (Lynch et al., 2000) . In human colon cancers, Cdx1 expression increases in few adenomas and carcinomas but decreases or is even lost in the majority of carcinomas (Mallo et al., 1997; Silberg et al., 1997; Vider et al., 1997; Domon-Dell et al., 2003; Pilozzi et al., 2004) . The aim of this study was to decipher the role of Cdx1 in the normal gut and the consequences of its alterations in intestinal cancers, using loss-and gain-of-function approaches in mice.
The phenotype of Cdx1 À/À mice has already been reported, except for the gut (Subramanian et al., 1995) , and we confirmed here the loss of Cdx1 expression in the intestinal epithelium by reverse transcription (RT)-PCR and immunohistochemistry ( Figure 1 ). Next, we produced Vil-Cdx1 transgenic mice (lines no. 319, no. 350 and no. 374) to overexpress Cdx1 in the gut epithelium under the Villin promoter (the validation of the VilCdx1 transgene is shown in Supplementary Figures 1A-C) . Overexpression of Cdx1 had no effect on Villin (Supplementary Figure 1D) . Transgenic mice were undistinguishable from wild types as regards growth, body weight, body size and survival. The Vil-Cdx1 transcript was expressed all along the gut (Figure 1 ), leading to a modest increase of Cdx1 protein in the small intestinal crypts but a massive overexpression in the villi, and to its overexpression in the apical cells of the cuffs in the colon (Figure 1 , line no. 350). In the lines no. 319 and 374, the transgene showed a mosaic pattern ( Figures 2B and C) .
The intestine of newborn, adult and 20-months elderly Cdx1
À/À and Vil-Cdx1 mice (n>20) was macroscopically and histologically normal. Cell proliferation in the crypts (Ki67 immunostaining) and migration along the crypt-villus axis (bromodeoxyuridine pulse labelling) were unchanged ( Supplementary Figures 2A  and B) . Thus, the proliferative or anti-proliferative effects attributed to Cdx1 in cell culture are blunted in vivo in the normal intestine, although Cdx1 is proliferative under unusual situations, such as pRb and p130 deficiency (Haigis et al., 2006) . Enzymatic staining of alkaline phosphatase and immunolabelling of Muc2, chromogranin-A and lysozyme demonstrated a correct specification of the absorptive, mucus-secreting, enteroendocrine and Paneth cell lineages (Supplementary Figure 2C) . Hence, changing the levels of Cdx1, both up or down, did not perturb intestinal architecture, cell renewal and cell type specification. Yet a subtle modification occurred in the distal colon of Cdx1 À/À mice where Muc2 expression extended deeper downwards the glands compared to wild-type animals (Supplementary Figure 2D) . The absence of morphological phenotype in the gut of Cdx1 À/À mice contrasts with the phenotype of gastric-type heteroplasia reported in Cdx2 þ /À animals (Beck et al., 1999) . Since Cdx1, like Cdx2, exhibits the intrinsic capacity of driving the intestinal fate when ectopically expressed (Mutoh et al., 2004) , these data suggest that Cdx2 compensates for Cdx1 deficiency in the gut, as it precedes and is necessary for Cdx1 onset during intestinal development Bonhomme et al., 2003) .
Since the onset of Cdx1 requires Cdx2 in the developing gut (Bonhomme et al., 2003) , we reciprocally asked if changing the Cdx1 levels has any effect on Cdx2. In the distal colon, where the Cdx1 level is the highest while Cdx2 is limited to the upper one-third of the glands, Cdx1 deficiency in Cdx1 À/À mice increased Cdx2, which appeared deeper in the glands (Figure 2A ). Conversely, the massive expression of Cdx1 in the villi of Vil-Cdx1 mice (no. 350) caused the loss of Cdx2, although the effect was fainter in crypts ( Figure 2B ). This was corroborated by the inverse picture between Cdx1-and Cdx2-expressing cells in mice no. 319 and no. 374 characterized by a mosaic pattern of the transgene ( Figures 2B and C) . In line with these data, Cdx2 was also down upon Cdx1 overexpression in the distal colon ( Figure 2A) . Thus, the massive increase of Cdx1 expression negatively regulates Cdx2. Consequently, Cdx1 may fine-tune the activity of Cdx2, as illustrated by the fact that two targets of Cdx2, Muc4 and Muc2, show a deeper expression in the colonic glands of Cdx1 À/À mice, like as Cdx2 (Jonkheere et al., 2007 78/id; see Supplementary Figure 2D ). Cell transfection experiments were performed using the Cdx1-expression plasmid pCB6-HA-CDX1 in an attempt to delineate the mechanism of downregulation of Cdx2 by Cdx1. There was no reduction of the endogenous level of Cdx2 protein and of the activity of the 9-kb Cdx2 promoter by Cdx1 overexpression in Caco2/TC7 ( Supplementary Figures 2A and B) , SW480 and T84 cells (not shown), indicating that the downregulatory effect exerted by Cdx1 on Cdx2 in the mouse intestinal epithelium is not reproduced in colon cancer cells in culture. . Histological staining (Harris) illustrates a low-grade dysplasia in Apc D14/ þ mice (a) and a typical adenocarcinoma (g) with infiltration (m) in Apc D14/ þ Â Vil-Cdx1 mice. The lesion immunostained in Apc D14/ þ mice corresponds to a lowgrade dysplasia with foci of high-grade dysplasia. In the lesion of Apc D14/ þ mice, arrowheads show area of low-grade dysplasia with nuclear Cdx1 and Cdx2 and membranous b-catenin, and arrows show area of high-grade dysplasia with a strong reduction of Cdx1 and Cdx2 proteins and cytoplasmic translocation of b-catenin. In high-grade dysplasia of Apc D14/ þ Â Vil-Cdx1 and in regions of infiltration, the levels of Cdx1 and Cdx2 are very low and b-catenin appears strongly in the nuclei, mostly at the interface with the stroma (arrowheads). Inserts correspond to immunostainings of morphologically normal crypt-villi adjacent to the tumours. The bar is 100 mm, except in (a) and (g) where it is 200 mm.
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Because the expression of Cdx1 increases in few cases of human colon tumours, we addressed its effect on intestinal tumourigenesis. For this purpose, Vil-Cdx1 transgenics and wild-type littermates were treated with the mutagenic agent azoxymethane (AOM). We found no significant difference in colon tumour incidence and tumour grade between Vil-Cdx1 and wild-type mice (Table 1 ). The endogenous level of Cdx1 being higher in the distal colon than in the small intestine, while the transgene is more active in the small intestine than in the colon, the rate of overexpression is lower in the colon than in the small intestine in Vil-Cdx1 transgenics. Thus, we reconsidered the effect of Cdx1 overexpression in a model of small intestinal cancer. Vil-Cdx1 mice were mated with Apc D14/ þ mice and tumour development was compared in Apc D14/ þ and Apc D14/ þ Â Vil-Cdx1 littermates. Tumour incidence was not statistically different between Apc D14/ þ and Apc D14/ þ Â Vil-Cdx1 mice (Table 1 ). The same was observed using another Apc allele, Apc 1638/ þ (not shown). However, the lesions were more severe in Apc D14/ þ Â Vil-Cdx1 compared to Apc D14/ þ animals (n ¼ 32, Po0.01) since 80% were low-grade dysplasia and 20% low-grade dysplasia with high-grade foci in Apc D14/ þ animals ( Figure 3a) , whereas 90% of the lesions were high-grade dysplasia in Apc D14/ þ Â Vil-Cdx1 mice (Figure 3g ), of which 20% showed infiltration into the submucosa with an active stroma reaction (Figure 3m ). Cdx1 immunostaining in the tumours of both Apc D14/ þ and Apc D14/ þ Â Vil-Cdx1 mice showed that not only the endogenous protein, but also the protein encoded by the transgene dropped in malignant cells (Figure 3b ). The Villin protein also decreased in tumours, although less than Cdx1. Cell proliferation was similar in the tumours of Apc D14/ þ and Apc D14/ þ Â Vil-Cdx1 mice. As markers of tumour progression, Cdx2 expression was reduced in the tumours of Apc D14/ þ and Apc D14/ þ Â Vil-Cdx1 mice, with the exception of the single surface epithelial layer. In low-grade dysplasia, b-catenin was membranous, whereas it became nuclear/ cytoplasmic in high-grade dysplasia of Apc D14/ þ Â Vil-Cdx1 mice and in the foci of high-grade dysplasia in Apc D14/ þ animals. Massive nuclear translocation of b-catenin occurred at the tumour border facing the stroma, as in human colorectal cancers (Brabletz et al., 2004) .
Next, Cdx1
À/À mice were used to address the consequence of the loss of Cdx1 frequently reported in human colon carcinoma. No spontaneous tumour appeared even in elderly animals. Then, Cdx1
À/À and wild-type mice were treated with AOM. As shown in Table 1 , tumour incidence was similar for both genotypes, and no histological difference was identified between the tumours of Cdx1 À/À and wild-type mice (not shown). Therefore, the loss of Cdx1 expression does not preserve or hypersensitize mice to chemically induced colon cancer.
In conclusion, despite its important role in anteroposterior patterning of the body axis (Subramanian et al., 1995) Cdx1 is dispensable for intestinal development and homeostasis. During intestinal carcinogenesis, Cdx1 overexpression may increase the severity of malignancy at least transiently at early stages in the case of small intestinal tumours, before being lost in advanced tumours by promoter hypermethylation and allelic loss (Domon-Dell et al., 2003; Pilozzi et al., 2004) . The relatively limited impact of Cdx1 on intestinal development and cancer is in clear opposition with Cdx2 that controls intestinal morphogenesis (Beck et al., 1999) and is a tumour suppressor in the colon (Aoki et al., 2003; Bonhomme et al., 2003) . Thus, there is a functional hierarchy among Cdx genes in the gut, together with an interrelation since Cdx2 is required for Cdx1 onset in the endoderm (Bonhomme et al., 2003) , whereas Cdx1 downregulates Cdx2 in the adult gut.
